Thus, here we identify a novel Cdh1-Rock2 pathway that is involved in Aβ neurotoxicity, which may open a new avenue for the development of therapeutic strategies to combat cognitive impairment in AD. This evidence concerns the gene ROCK2 and Alzheimer disease.